As­traZeneca says CMS guid­ance around IRA ex­emp­tions is 'un­law­ful' in lat­est court brief

As­traZeneca ar­gued in court on Fri­day that the gov­ern­ment’s rules around which drugs may be ex­empt from Medicare price ne­go­ti­a­tions un­der the In­fla­tion Re­duc­tion Act …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER